Nirsevimab Library
This is a collection of current resources related to Nirsevimab.
Clinical Progression Scale-Pediatrics: A Potential Metric of Respiratory Syncytial Virus Severity and Progression in Children
This editorial comments on a study titled "Assessing Clinical Improvement of Infants Hospitalized for Respiratory Syncytial Virus–Related Critical Illness" by Leland et al. 2025. It …
Ask aRCie
RSV Immunization Uptake Among Infants and Pregnant Persons — Wisconsin, October 1, 2023 - March 31, 2024
This short communication looks at new prevention strategies, such as the maternal RSVpreF vaccine and nirsevimab monoclonal antibody for prevention of RSV among infants. It …
RSV Prevention in Infants: Promising Products, But at What Cost?
This commentary is related to two studies on the cost-effectiveness of maternal vaccination and nirsevimab for infants for the prevention of respiratory syncytial virus (RSV). …
Respiratory Syncytial Virus Vaccine and Nirsevimab Uptake Among Pregnant People and Their Neonates
This study was conducted to describe the uptake of the prenatal RSVpreF vaccine and infant nirsevimab during the 2023-2024 RSV season. It found high uptake …
Maternal RSVpreF and Infant Nirsevimab Immunizations Uptake During Respiratory Syncytial Virus Season
This research letter looks at a study that analyzed the uptake of RSVpreF vaccination during pregnancy and nirsevimab administration to infants during the 2023 to …
New and Emerging Passive Immunization Strategies for the Prevention of RSV Infection During Infancy
This article discusses new ways to protect babies from RSV, a virus causing lung infections. Two methods were approved in 2023: one uses a long-lasting …
Uptake of Maternal RSV Vaccination and Infant Nirsevimab Among Infants Born October 2023 to March 2024
2025
· Kaiser Permanente
The article investigates the uptake of maternal RSV vaccination and infant nirsevimab among infants born from October 2023 to March 2024 within Kaiser Permanente Northern …
Efficacy of Nirsevimab Against Respiratory Syncytial Virus Lower Respiratory Tract Infections in Preterm and Term Infants, and Pharmacokinetic Extrapolation to Infants With Congenital Heart Disease and Chronic Lung Disease: A Pooled Analysis of Randomised Controlled Trials
2023
· Children's Hospital Colorado,
· University of the Witwatersrand,
· Northwestern University,
· Dr. Georgi Stranski University Hospital,
· Quironsalud Madrid University Hospital,
· State University of New York - Upstate Medical University
This article describes a study on the effectiveness of nirsevimab in preventing respiratory syncytial virus (RSV) infections in infants. It focuses on both preterm and …
Review and Update of Active and Passive Immunization Against Respiratory Syncytial Virus
This article reviews ways to protect against respiratory syncytial virus (RSV). It describes both active and passive immunization methods. Active immunization involves vaccines that help …
Impact of Nirsevimab Prophylaxis on Paediatric Respiratory Syncytial Virus (RSV)-Related Hospitalisations During the Initial 2023/24 Season in Luxembourg
2024
· European Centre for Disease Prevention and Control (ECDC),
· European Centre for Disease Prevention and Control (ECDC),
· Centre Hospitalier de Luxembourg
This study examines the impact of nirsevimab, a new antibody, on reducing RSV-related hospitalizations in Luxembourg during the 2023/24 season. After its introduction, neonatal coverage …